Human Gut Microbiota and Drug Metabolism

被引:0
作者
Archana Pant
Tushar K. Maiti
Dinesh Mahajan
Bhabatosh Das
机构
[1] National Institute of Immunology,Molecular Genetics Lab
[2] NCR Biotech Science Cluster,Regional Centre for Biotechnology
[3] Translational Health Science and Technology Institute,Molecular Genetics Laboratory
[4] NCR Biotech Science Cluster,Chemistry and Pharmacology Lab
[5] Translational Health Science and Technology Institute,undefined
[6] NCR Biotech Science Cluster,undefined
来源
Microbial Ecology | 2023年 / 86卷
关键词
Gut microbiome; Drug metabolism; Xenobiotics; Biotransformation; Genetic ecology;
D O I
暂无
中图分类号
学科分类号
摘要
The efficacy of drugs widely varies in individuals, and the gut microbiota plays an important role in this variability. The commensal microbiota living in the human gut encodes several enzymes that chemically modify systemic and orally administered drugs, and such modifications can lead to activation, inactivation, toxification, altered stability, poor bioavailability, and rapid excretion. Our knowledge of the role of the human gut microbiome in therapeutic outcomes continues to evolve. Recent studies suggest the existence of complex interactions between microbial functions and therapeutic drugs across the human body. Therapeutic drugs or xenobiotics can influence the composition of the gut microbiome and the microbial encoded functions. Both these deviations can alter the chemical transformations of the drugs and hence treatment outcomes. In this review, we provide an overview of (i) the genetic ecology of microbially encoded functions linked with xenobiotic degradation; (ii) the effect of drugs on the composition and function of the gut microbiome; and (iii) the importance of the gut microbiota in drug metabolism.
引用
收藏
页码:97 / 111
页数:14
相关论文
共 890 条
  • [1] Morowitz MJ(2011)Contributions of intestinal bacteria to nutrition and metabolism in the critically Ill Surg Clin North Am 91 771-785
  • [2] Carlisle E(2015)Dysbiosis of the gut microbiota in disease Microb Ecol Health Dis 26 26191-89
  • [3] Alverdy JC(2017)Gut microbiota: role in pathogen colonization, immune responses and inflammatory disease Immunol Rev 279 70-300
  • [4] Carding S(2007)Liver regeneration J Cell Physiol 213 286-116
  • [5] Verbeke K(2020)The Firmicutes/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 12 1474-56
  • [6] Vipond DT(2019)What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases Microorganisms 7 14-272
  • [7] Corfe BM(2017)Chemical transformation of xenobiotics by the human gut microbiota Science 356 1246-1836
  • [8] Owen LJ(2010)Phase II drug metabolizing enzymes Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154 103-725
  • [9] Pickard JM(2012)Xenobiotic metabolomics: major impact on the metabolome Annu Rev Pharmacol Toxicol 52 37-971
  • [10] Zeng MY(2011)Ecology and physiology of the intestinal tract Curr Top Microbiol Immunol 358 247-141